Nach Genre filtern
Mind Moments®, a podcast from NeurologyLive® (https://www.neurologylive.com/) , brings you exclusive interviews with experts in neurologic disorders. Listen in to hear the latest clinical and research updates from major medical conferences, as well as insights on the management of complex disorders, including epilepsy, migraine, Alzheimer disease, stroke, multiple sclerosis, Parkinson disease, and more. For more expert insight into neurology, visit NeurologyLive.com (https://www.neurologylive.com/) .
127 - 114: Phase 3 PHOENIX Study, AMX0035, and Amylyx's Future Drug Development
0:00 / 0:00
1x
- 127 - 114: Phase 3 PHOENIX Study, AMX0035, and Amylyx's Future Drug DevelopmentFri, 03 May 2024
- 126 - Special Episode: FDA Approval of Diazepam Buccal Film for Pediatric SeizuresWed, 01 May 2024
- 125 - 113: Lessons Learned in Alzheimer Drug DevelopmentFri, 19 Apr 2024
- 124 - 112: Exploring Dimethyl Fumarate to Treat Friedreich AtaxiaFri, 05 Apr 2024
- 123 - Special Episode: FDA Approval of Givinostat for Duchenne Muscular DystrophyFri, 29 Mar 2024
- 122 - 111: Reviewing ACTRIMS 2024Fri, 22 Mar 2024
- 121 - 110: Differential Diagnosis of Sleep Disorders and HypersomniasFri, 08 Mar 2024
- 120 - 109: AB126, Exosomes, and Cerebroprotection for StrokeFri, 23 Feb 2024
- 119 - 108: Advancing the Genetic Pool of Parkinson DiseaseFri, 09 Feb 2024
- 118 - 107: Revealing Mechanisms of Sudden Unexplained Death in ToddlersFri, 26 Jan 2024
- 117 - 106: Potential Role of Stathmin-2 in Amyotrophic Lateral SclerosisFri, 12 Jan 2024
- 116 - 105: Recapping Conversations in Neurology From 2023Fri, 29 Dec 2023
- 115 - 104: Effects of Once-Nightly Sodium Oxybate on Narcolepsy Type 1 and 2Fri, 15 Dec 2023
- 114 - 103: Advancing Epilepsy Care and Seizure Localization in PediatricsFri, 01 Dec 2023
- 113 - 102: Potential of Gamma Sensory Stimulation in Alzheimer DiseaseFri, 17 Nov 2023
- 112 - Special Episode: FDA Greenlights Vamorolone for Duchenne Muscular DystrophyTue, 07 Nov 2023
- 111 - 101: Ways to Enhance Neuromodulation in ParkinsonismFri, 03 Nov 2023
- 110 - Special Episode: FDA Approves Zilucoplan for Myasthenia GravisMon, 23 Oct 2023
- 109 - 100: 2023 ECTRIMS-ACTRIMS Meeting HighlightsFri, 20 Oct 2023
- 108 - 99: Understanding AMX0035's Potential in Progressive Supranuclear PalsyThu, 05 Oct 2023
- 107 - 98: Uncovering Phenotypical Features of Narcolepsy Type 1Fri, 22 Sep 2023
- 106 - 97: Identifying Gaps in Access to Parkinson Disease CareFri, 08 Sep 2023
- 105 - 96: Complexities With Cognitive Screening in Primary Care SettingsFri, 25 Aug 2023
- 104 - Special Episode: Addition of Valbenazine to Treat Huntington Disease ChoreaMon, 21 Aug 2023
- 103 - 95: Expanding Potential for Long-Term Treatment in SMAFri, 11 Aug 2023
- 102 - 94: The Discussion Surrounding Lecanemab's Approval for Alzheimer DiseaseFri, 28 Jul 2023
- 101 - 93: Caring for Women With Parkinson DiseaseFri, 14 Jul 2023
- 100 - 92: Highlights From the 2023 CMSC, SLEEP, AHS, and ATMRD Annual MeetingsFri, 30 Jun 2023
- 99 - Special Episode: SRP-9001 Approved As First Gene Therapy for Duchenne Muscular DystrophyThu, 22 Jun 2023
- 98 - 91: Assessing the Landscape of Sleep Disorder CareFri, 16 Jun 2023
- 97 - 90: Raising Stroke Awareness and Improving Clinical CareFri, 02 Jun 2023
- 96 - 89: Potential of CNM-Au8 Gold Nanocrystals to Treat ALSFri, 19 May 2023
- 95 - 88: 2023 AAN Annual Meeting HighlightsFri, 05 May 2023
- 94 - Special Episode: Tofersen Approved for SOD1 ALSTue, 25 Apr 2023
- 93 - 87: Severe Multiple Sclerosis and the CASA-MS StudyFri, 21 Apr 2023
- 92 - 86: Pimavanserin and Atypical Antipsychotics to Treat Parkinson Disease PsychosisFri, 07 Apr 2023
- 91 - 85: Impact of Narcolepsy on Social Relationship Health in AdolescentsFri, 24 Mar 2023
- 90 - Special Episode: Trofinetide Approved for Rett SyndromeMon, 13 Mar 2023
- 89 - 84: Parkinson Disease Education for Community ProvidersFri, 10 Mar 2023
- 88 - 83: The ARISE Study and Using DMTs in RISFri, 24 Feb 2023
- 87 - 82: Managing Seizures After Ischemic StrokeFri, 10 Feb 2023
- 86 - 81: Widening the Therapeutic Window in Parkinson DiseaseFri, 27 Jan 2023
- 85 - 80: Advancing Treatment for Rare Neuromuscular DisordersFri, 13 Jan 2023
- 84 - Special Episode: Lecanemab Approved for Alzheimer DiseaseMon, 09 Jan 2023
- 83 - 79: A New Monoclonal for Alzheimer DiseaseFri, 16 Dec 2022
- 82 - 78: A Virtual Reality Platform for Parkinson DiseaseFri, 02 Dec 2022
- 81 - 77: A New Era of Myasthenia Gravis TreatmentFri, 18 Nov 2022
- 80 - 76: ECTRIMS 2022 and the Latest in MS AdvancesFri, 04 Nov 2022
- 79 - 75: Focusing on the Future of NeurologyFri, 21 Oct 2022
- 78 - 74: Prescription Digital Therapeutics for InsomniaFri, 07 Oct 2022
- 77 - 73: The Role of Palliative Care in NeurologyFri, 23 Sep 2022
- 76 - 72: Updates in Epilepsy TreatmentFri, 09 Sep 2022
- 75 - 71: Pediatric Sleep and School Start TimesFri, 26 Aug 2022
- 74 - 70: Raising Awareness of Acute Flaccid MyelitisFri, 12 Aug 2022
- 73 - 69: The Widespread Effects of DMT Waste in Multiple SclerosisFri, 29 Jul 2022
- 72 - 68: Updates in Essential Tremor CareFri, 15 Jul 2022
- 71 - 67: Mental Health and Advocacy in Pediatric MigraineFri, 01 Jul 2022
- 70 - 66: 2022 SLEEP Annual Meeting HighlightsFri, 17 Jun 2022
- 69 - Special Episode: Aducanumab and Anti-Amyloid-ß, One Year LaterTue, 07 Jun 2022
- 68 - 65: 2022 CMSC Annual Meeting HighlightsSat, 04 Jun 2022
- 67 - 64: Genetics, Advocacy, and Big Data in ALSFri, 20 May 2022
- 66 - 63: Moving Migraine Toward Personalized CareFri, 06 May 2022
- 65 - 62: Advanced Therapeutics in Parkinson and Movement DisordersFri, 22 Apr 2022
- 64 - 61: 2022 AAN Annual Meeting HighlightsSat, 09 Apr 2022
- 63 - Special Episode: Ganaxolone Approved for CDD, Fenfluramine Approved for LGSWed, 30 Mar 2022
- 62 - 60: Improving Care and Raising Awareness for NMOSDFri, 25 Mar 2022
- 61 - Special Episode: Heart Health in NarcolepsyFri, 18 Mar 2022
- 60 - 59: AASM's Push to End Daylight Saving TimeFri, 11 Mar 2022
- 59 - 58: Addressing Parkinson Disease Virtually With Prime PDFri, 25 Feb 2022
- 58 - 57: Invisible Symptoms: Cognition and MSFri, 11 Feb 2022
- 57 - 56: Epstein-Barr Virus's Relationship With Multiple SclerosisFri, 28 Jan 2022
- 56 - 55: Treating Headache in the Emergency DepartmentFri, 14 Jan 2022
- 55 - Special Episode: Daridorexant Approved for InsomniaTue, 11 Jan 2022
- 54 - 54: The Shortage of NeurologistsFri, 31 Dec 2021
- 53 - 53: A Landmark Year for Alzheimer DiseaseFri, 17 Dec 2021
- 52 - 52: Treating Pediatric MigraineFri, 03 Dec 2021
- 51 - 51: The State of Sleep MedicineFri, 19 Nov 2021
- 50 - 50: Genetic Testing for Huntington DiseaseFri, 05 Nov 2021
- 49 - 49: Altering the View of MS With a Topographical ModelFri, 22 Oct 2021
- 48 - 48: RapidAI's Effect on Stroke ImagingFri, 08 Oct 2021
- 47 - 47: Incorporating Physical Therapy Into MS CareFri, 24 Sep 2021
- 46 - 46: Tackling Barriers to Migraine CareFri, 10 Sep 2021
- 45 - 45: Small Victories: Advancing Care in Parkinson DiseaseFri, 27 Aug 2021
- 44 - 44: AHA/ASA Updates to the Stroke Care ModelFri, 13 Aug 2021
- 43 - 43: Is Telehealth Here to Stay for Alzheimer Disease Care?Fri, 30 Jul 2021
- 42 - 42: The Importance of Sleep for Overall HealthFri, 16 Jul 2021
- 41 - 41: Consensus MRI Guidelines for MSFri, 02 Jul 2021
- 40 - 40: SLEEP 2021: Topline Data, Telemedicine, and TakeawaysFri, 18 Jun 2021
- 39 - 39: A Controversial FDA DecisionFri, 11 Jun 2021
- 38 - 38: Advancing MS Care and AwarenessFri, 04 Jun 2021
- 37 - 37: The Impact of Awareness Efforts in ALSFri, 21 May 2021
- 36 - 36: Zavegepant and the Gepant Class for Migraine CareFri, 07 May 2021
- 35 - 35: Highlights From the AAN Annual MeetingFri, 30 Apr 2021
- 34 - 34: Hope and the Huntington Disease PipelineFri, 23 Apr 2021
- 33 - 33: Problem Recognition: Cerebral Palsy DiagnosisFri, 09 Apr 2021
- 32 - 32: The Gaps in Migraine Care for WomenFri, 26 Mar 2021
- 31 - 31: The Pipeline Pendulum in Parkinson DiseaseFri, 12 Mar 2021
- 30 - 30: Cognitive Behaviorial Therapy for InsomniaFri, 26 Feb 2021
- 29 - 29: Developing A Seizure Action PlanFri, 12 Feb 2021
- 28 - 28: The Multiple Sclerosis Patient JourneyFri, 29 Jan 2021
Weitere Folgen anzeigen
5Podcasts ähnlich wie NeurologyLive® Mind Moments®
- Global News Podcast BBC World Service
- El Partidazo de COPE COPE
- Herrera en COPE COPE
- The Dan Bongino Show Cumulus Podcast Network | Dan Bongino
- Es la Mañana de Federico esRadio
- La Noche de Dieter esRadio
- Hondelatte Raconte - Christophe Hondelatte Europe 1
- Dateline NBC NBC News
- 財經一路發 News98
- La rosa de los vientos OndaCero
- Más de uno OndaCero
- La Zanzara Radio 24
- L'Heure Du Crime RTL
- El Larguero SER Podcast
- Nadie Sabe Nada SER Podcast
- SER Historia SER Podcast
- Todo Concostrina SER Podcast
- 安住紳一郎の日曜天国 TBS RADIO
- TED Talks Daily TED
- アンガールズのジャンピン[オールナイトニッポンPODCAST] ニッポン放送
- 辛坊治郎 ズーム そこまで言うか! ニッポン放送
- 飯田浩司のOK! Cozy up! Podcast ニッポン放送
- 吳淡如人生實用商學院 吳淡如
- 武田鉄矢・今朝の三枚おろし 文化放送PodcastQR